Trial Profile
Hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma: Prospective randomized study.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2020
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Deferoxamine
- Indications Liver cancer
- Focus Therapeutic Use
- 15 Jun 2020 Status changed from recruiting to discontinued.
- 05 Sep 2011 New trial record